Prof Kelly Chibale joined the University of Cape Town (UCT) as a lecturer in 1996 and became a full Professor of Organic Chemistry in 2007. A year later he was warded a Tier 1 South Africa Research Chair in Drug Discovery under the South Africa Research Chairs Initiative. In 2009, Prof Chibale founded the South African Medical Research Council's Drug Discovery and Development Research Unit at UCT and was elected a Life Fellow of UCT and a Fellow of the Royal Society of South Africa.
Click on the title to read more
In 2010 Prof Chibale became the founding Director of the UCT Drug Discovery and Development Centre (H3-D), a position he still holds, together with full membership of the UCT Institute of Infectious Disease and Molecular Medicine.
Prof Chibale obtained his PhD in synthetic organic chemistry from the University of Cambridge in 1992 and followed this with postdoctoral stints at the University of Liverpool and the Scripps Research Institute in the USA as a Wellcome Trust International Prize Research Fellow. He has been a Sandler Sabbatical Fellow at the University of California San Francisco (2002), a US Fulbright Senior Research Scholar at the University of Pennsylvania (2008) and a Visiting Professor at Pfizer in the UK (2008). His research has been in the field of drug discovery and has been underpinned by (Hit to Lead and Lead Optimization) medicinal chemistry.
Log in to read the attachment